Skip to main content
Top
Published in: AIDS and Behavior 1/2017

01-01-2017 | Original Article

Disclosure of HIV Status Beyond Sexual Partners by People Living with HIV in France: A Call for Help? Results from the National Cross-Sectional Survey ANRS-VESPA2

Authors: Fabienne Marcellin, Marie Suzan-Monti, Antoine Vilotitch, Luis Sagaon-Teyssier, Marion Mora, Rosemary Dray-Spira, Marie Préau, France Lert, Bruno Spire, The ANRS VESPA2 Study Group

Published in: AIDS and Behavior | Issue 1/2017

Login to get access

Abstract

HIV status disclosure remains a complex issue for most people living with HIV (PLWH). We analyzed PLWH disclosure behaviors in France, where treatment is free and where the social image of HIV has improved in the general population. Analyses focused on disclosure to the social network excluding sexual partners (close family, other relatives, friends, colleagues). The study sample comprised 3016 participants from the nationally representative survey ANRS-VESPA2. Three PLWH clusters were identified using hierarchical classification (“high disclosure level”: 28.2 %, “medium disclosure level”: 27.5 %, and “low disclosure level”: 44.3 %). In multivariable analyses, the variable “not living in a couple but psychological social support needed” was independently associated with medium (AOR [95 % CI] 1.8 [1.4; 2.3]) and high levels of disclosure (1.4 [1.1; 1.8]) (multinomial regression models). For PLWH living alone, HIV status disclosure may reveal a need for psychological social support, a key component to treatment adherence and positive prevention.
Literature
1.
go back to reference Dima AL, Stutterheim SE, Lyimo R, de Bruin M. Advancing methodology in the study of HIV status disclosure: the importance of considering disclosure target and intent. Soc Sci Med. 2014;108:166–74.PubMedCrossRef Dima AL, Stutterheim SE, Lyimo R, de Bruin M. Advancing methodology in the study of HIV status disclosure: the importance of considering disclosure target and intent. Soc Sci Med. 2014;108:166–74.PubMedCrossRef
2.
go back to reference Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, et al. Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antivir Ther. 2008;13(5):697–703.PubMed Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, et al. Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antivir Ther. 2008;13(5):697–703.PubMed
3.
go back to reference Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20(1):29–50.PubMedCrossRef Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20(1):29–50.PubMedCrossRef
4.
go back to reference Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y, VESPA Group. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care. 2006;18(3):254–61.PubMedCrossRef Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y, VESPA Group. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care. 2006;18(3):254–61.PubMedCrossRef
5.
go back to reference Bouhnik A-D, Préau M, Schiltz M-A, Lert F, Obadia Y, Spire B, et al. Unprotected sex in regular partnerships among homosexual men living with HIV: a comparison between sero-nonconcordant and seroconcordant couples (ANRS-EN12-VESPA Study). AIDS Lond Engl. 2007;21(Suppl 1):S43–8.CrossRef Bouhnik A-D, Préau M, Schiltz M-A, Lert F, Obadia Y, Spire B, et al. Unprotected sex in regular partnerships among homosexual men living with HIV: a comparison between sero-nonconcordant and seroconcordant couples (ANRS-EN12-VESPA Study). AIDS Lond Engl. 2007;21(Suppl 1):S43–8.CrossRef
6.
go back to reference Thanawuth N, Rojpibulstit M. Sexual risk behaviors among HIV-patients receiving antiretroviral therapy in Southern Thailand: roles of antiretroviral adherence and serostatus disclosure. AIDS Care. 2015;14:1–8. Thanawuth N, Rojpibulstit M. Sexual risk behaviors among HIV-patients receiving antiretroviral therapy in Southern Thailand: roles of antiretroviral adherence and serostatus disclosure. AIDS Care. 2015;14:1–8.
7.
go back to reference Chaudoir SR, Fisher JD, Simoni JM. Understanding HIV disclosure: a review and application of the disclosure processes model. Soc Sci Med. 2011;72(10):1618–29.PubMedPubMedCentralCrossRef Chaudoir SR, Fisher JD, Simoni JM. Understanding HIV disclosure: a review and application of the disclosure processes model. Soc Sci Med. 2011;72(10):1618–29.PubMedPubMedCentralCrossRef
8.
go back to reference Henry E, Bernier A, Lazar F, Matamba G, Loukid M, Bonifaz C, et al. Was it a mistake to tell others that you are infected with HIV?: factors associated with regret following HIV disclosure among people living with HIV in five countries (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). Results from a community-based research. AIDS Behav. 2015;19(2):311–21.PubMedCrossRef Henry E, Bernier A, Lazar F, Matamba G, Loukid M, Bonifaz C, et al. Was it a mistake to tell others that you are infected with HIV?: factors associated with regret following HIV disclosure among people living with HIV in five countries (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). Results from a community-based research. AIDS Behav. 2015;19(2):311–21.PubMedCrossRef
9.
go back to reference Préau M, Beaulieu-Prévost D, Henry E, Bernier A, Veillette-Bourbeau L, Otis J. HIV serostatus disclosure: development and validation of indicators considering target and modality. Results from a community-based research in five countries. Soc Sci Med. 2015;146:137–46.PubMedCrossRef Préau M, Beaulieu-Prévost D, Henry E, Bernier A, Veillette-Bourbeau L, Otis J. HIV serostatus disclosure: development and validation of indicators considering target and modality. Results from a community-based research in five countries. Soc Sci Med. 2015;146:137–46.PubMedCrossRef
10.
go back to reference Gadisa T, Tymejczyk O, Kulkarni SG, Hoffman S, Lahuerta M, Remien RH, et al. Disclosure history among persons initiating antiretroviral treatment at six HIV clinics in Oromia, Ethiopia, 2012–2013. AIDS Behav. 2016;18:1–12. Gadisa T, Tymejczyk O, Kulkarni SG, Hoffman S, Lahuerta M, Remien RH, et al. Disclosure history among persons initiating antiretroviral treatment at six HIV clinics in Oromia, Ethiopia, 2012–2013. AIDS Behav. 2016;18:1–12.
11.
go back to reference Simbayi LC, Zungu N, Evans M, Mehlomakulu V, Kupamupindi T, Mafoko G, et al. HIV Serostatus Disclosure to sexual partners among sexually active people living with HIV in South Africa: results from the 2012 National population-based household survey. AIDS Behav. 2016;14:1–11. Simbayi LC, Zungu N, Evans M, Mehlomakulu V, Kupamupindi T, Mafoko G, et al. HIV Serostatus Disclosure to sexual partners among sexually active people living with HIV in South Africa: results from the 2012 National population-based household survey. AIDS Behav. 2016;14:1–11.
12.
go back to reference Ahn JV, Bailey H, Malyuta R, Volokha A, Thorne C. Ukraine cohort of HIV-infected childbearing women in EuroCoord. Factors associated with non-disclosure of HIV status in a cohort of childbearing HIV-positive women in Ukraine. AIDS Behav. 2016;20(1):174–83.PubMedCrossRef Ahn JV, Bailey H, Malyuta R, Volokha A, Thorne C. Ukraine cohort of HIV-infected childbearing women in EuroCoord. Factors associated with non-disclosure of HIV status in a cohort of childbearing HIV-positive women in Ukraine. AIDS Behav. 2016;20(1):174–83.PubMedCrossRef
13.
go back to reference Go VF, Latkin C, Le Minh N, Frangakis C, Ha TV, Sripaipan T, et al. Variations in the role of social support on disclosure among newly diagnosed HIV-infected people who inject drugs in Vietnam. AIDS Behav. 2016;20(1):155–64.PubMedPubMedCentralCrossRef Go VF, Latkin C, Le Minh N, Frangakis C, Ha TV, Sripaipan T, et al. Variations in the role of social support on disclosure among newly diagnosed HIV-infected people who inject drugs in Vietnam. AIDS Behav. 2016;20(1):155–64.PubMedPubMedCentralCrossRef
14.
go back to reference Obiri-Yeboah D, Amoako-Sakyi D, Baidoo I, Adu-Oppong A, Rheinländer T. The ‘Fears’ of disclosing HIV status to sexual partners: a mixed methods study in a counseling setting in Ghana. AIDS Behav. 2016;20(1):126–36.PubMedCrossRef Obiri-Yeboah D, Amoako-Sakyi D, Baidoo I, Adu-Oppong A, Rheinländer T. The ‘Fears’ of disclosing HIV status to sexual partners: a mixed methods study in a counseling setting in Ghana. AIDS Behav. 2016;20(1):126–36.PubMedCrossRef
15.
go back to reference Cissé M, Diop S, Abadie A, Henry E, Bernier A, Fugon L, et al. Factors associated with hiv voluntary disclosure to one’s steady sexual partner in mali: results from a community-based study. J Biosoc Sci. 2016;48(1):51–65.PubMedCrossRef Cissé M, Diop S, Abadie A, Henry E, Bernier A, Fugon L, et al. Factors associated with hiv voluntary disclosure to one’s steady sexual partner in mali: results from a community-based study. J Biosoc Sci. 2016;48(1):51–65.PubMedCrossRef
16.
go back to reference Nobre NR, Kylmä J, Kirsi T, Pereira M. Social networks of older adults living with HIV in Finland. AIDS Care. 2016;28(2):186–90.PubMedCrossRef Nobre NR, Kylmä J, Kirsi T, Pereira M. Social networks of older adults living with HIV in Finland. AIDS Care. 2016;28(2):186–90.PubMedCrossRef
17.
go back to reference Kankou J, Bouchaud O, Lele N, Abgrall S. Déterminants de la révélation de l’infection VIH chez les migrants originaires d’Afrique sub-saharienne infectés par le VIH vivant en France : étude ANRS-VIHVO. Médecine Mal Infect. 2014;44:19–28. Kankou J, Bouchaud O, Lele N, Abgrall S. Déterminants de la révélation de l’infection VIH chez les migrants originaires d’Afrique sub-saharienne infectés par le VIH vivant en France : étude ANRS-VIHVO. Médecine Mal Infect. 2014;44:19–28.
18.
go back to reference Zola EK, Gifudu GM, Henry E, Bernier A, Masangu HM, Abadie A, et al. Factors associated with HIV voluntary disclosure of people living with HIV to their steady sexual partner in the Democratic Republic of the Congo: results from a community-based participatory research. Pan Afr Med J. 2014;19:276.PubMedPubMedCentral Zola EK, Gifudu GM, Henry E, Bernier A, Masangu HM, Abadie A, et al. Factors associated with HIV voluntary disclosure of people living with HIV to their steady sexual partner in the Democratic Republic of the Congo: results from a community-based participatory research. Pan Afr Med J. 2014;19:276.PubMedPubMedCentral
19.
go back to reference Loukid M, Abadie A, Henry E, Hilali MK, Fugon L, Rafif N, et al. Factors associated with HIV status disclosure to one’s steady sexual partner in PLHIV in Morocco. J Community Health. 2014;39(1):50–9.PubMedCrossRef Loukid M, Abadie A, Henry E, Hilali MK, Fugon L, Rafif N, et al. Factors associated with HIV status disclosure to one’s steady sexual partner in PLHIV in Morocco. J Community Health. 2014;39(1):50–9.PubMedCrossRef
20.
go back to reference Dray-Spira R, Spire B, Lert F, et le groupe Vespa2. General method of the ANRS-VESPA2 Study [in French]. Bull Epidémiologique Hebd. 2013;26(27):321–4. Dray-Spira R, Spire B, Lert F, et le groupe Vespa2. General method of the ANRS-VESPA2 Study [in French]. Bull Epidémiologique Hebd. 2013;26(27):321–4.
21.
go back to reference Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, et al. Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys). AIDS Care. 2014;26(Suppl 1):S29–40.PubMedCrossRef Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, et al. Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys). AIDS Care. 2014;26(Suppl 1):S29–40.PubMedCrossRef
22.
go back to reference Kessler R, Andrews G, Mroczek D, Ustun T, Wittchen H. The World Health Organization composite international diagnostic interview short form (CIDI-SF). Int J Methods Psychiatr Res. 1998;7(4):171–85.CrossRef Kessler R, Andrews G, Mroczek D, Ustun T, Wittchen H. The World Health Organization composite international diagnostic interview short form (CIDI-SF). Int J Methods Psychiatr Res. 1998;7(4):171–85.CrossRef
23.
go back to reference Heeb J-L, Gmel G. Measuring alcohol consumption: a comparison of graduated frequency, quantity frequency, and weekly recall diary methods in a general population survey. Addict Behav. 2005;30(3):403–13.PubMedCrossRef Heeb J-L, Gmel G. Measuring alcohol consumption: a comparison of graduated frequency, quantity frequency, and weekly recall diary methods in a general population survey. Addict Behav. 2005;30(3):403–13.PubMedCrossRef
24.
go back to reference Greenacre M. Correspondence analysis in medical research. Stat Methods Med Res. 1992;1(1):97–117.PubMedCrossRef Greenacre M. Correspondence analysis in medical research. Stat Methods Med Res. 1992;1(1):97–117.PubMedCrossRef
25.
go back to reference Moreno X, Sánchez H, Huerta M, Albala C, Márquez C. Social representations of older adults among chilean elders of three cities with different historical and sociodemographic background. J Cross-Cult Gerontol. 2016;31(2):115–28.PubMedCrossRef Moreno X, Sánchez H, Huerta M, Albala C, Márquez C. Social representations of older adults among chilean elders of three cities with different historical and sociodemographic background. J Cross-Cult Gerontol. 2016;31(2):115–28.PubMedCrossRef
26.
go back to reference Ruiz F, Vallet T, Pensé-Lhéritier A-M, Aoussat A. Standardized method to assess medicines’ acceptability: focus on paediatric population. J Pharm Pharmacol. 2016. doi:10.1111/jphp.12547.PubMed Ruiz F, Vallet T, Pensé-Lhéritier A-M, Aoussat A. Standardized method to assess medicines’ acceptability: focus on paediatric population. J Pharm Pharmacol. 2016. doi:10.​1111/​jphp.​12547.PubMed
27.
go back to reference Veneziani F, Panza F, Solfrizzi V, Capozzo R, Barulli MR, Leo A, et al. Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer’s disease: pass or fail? Int Psychogeriatr IPA. 2016;28(7):1111–24.CrossRef Veneziani F, Panza F, Solfrizzi V, Capozzo R, Barulli MR, Leo A, et al. Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer’s disease: pass or fail? Int Psychogeriatr IPA. 2016;28(7):1111–24.CrossRef
28.
go back to reference Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, et al. Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort. Antivir Ther. 2015;20(7):763–72.PubMedCrossRef Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, et al. Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort. Antivir Ther. 2015;20(7):763–72.PubMedCrossRef
30.
go back to reference Cavalcante MDS, Kerr LRFS, Brignol SMS, de Silva DO, Dourado I, Galvão MTG, et al. Sociodemographic factors and health in a population of children living in families infected with HIV in Fortaleza and Salvador Brazil. AIDS Care. 2013;25(5):550–8.CrossRef Cavalcante MDS, Kerr LRFS, Brignol SMS, de Silva DO, Dourado I, Galvão MTG, et al. Sociodemographic factors and health in a population of children living in families infected with HIV in Fortaleza and Salvador Brazil. AIDS Care. 2013;25(5):550–8.CrossRef
31.
go back to reference Kaufman L, Rousseeuw P. Finding groups in data: an introduction to cluster analysis. New York: Wiley; 1990.CrossRef Kaufman L, Rousseeuw P. Finding groups in data: an introduction to cluster analysis. New York: Wiley; 1990.CrossRef
32.
go back to reference Ward J. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963;58(301):236–44.CrossRef Ward J. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963;58(301):236–44.CrossRef
33.
go back to reference Marsicano E, Dray-Spira R, Lert F, Aubrière C, Spire B, Hamelin C, et al. Multiple discriminations experienced by people living with HIV in France: results from the ANRS-Vespa2 study. AIDS Care. 2014;16:1–10. Marsicano E, Dray-Spira R, Lert F, Aubrière C, Spire B, Hamelin C, et al. Multiple discriminations experienced by people living with HIV in France: results from the ANRS-Vespa2 study. AIDS Care. 2014;16:1–10.
34.
go back to reference Suzan-Monti M, Blanche J, Marcellin F, Dray-Spira R, Préau M, Lert F, et al. Living with HIV in France in 2011: correlates of HIV status disclosure to close family members, friends and colleagues (data from the national survey ANRS Vespa2)—XI International AIDS Impact Conference (abstract n°265). In Barcelona (Spain); 2013. Suzan-Monti M, Blanche J, Marcellin F, Dray-Spira R, Préau M, Lert F, et al. Living with HIV in France in 2011: correlates of HIV status disclosure to close family members, friends and colleagues (data from the national survey ANRS Vespa2)—XI International AIDS Impact Conference (abstract n°265). In Barcelona (Spain); 2013.
35.
go back to reference Dray-Spira R, Wilson-d’Almeida K, Aubrière C, Marcellin F, Spire B, Lert F, et al. Health status of people living with HIV followed at hospital in metropolitan France in 2011 and characteristics of those recently diagnosed Results of the ANRS VESPA2 study. Bull Epidémiologique Hebd. 2013;26(27):285–92. Dray-Spira R, Wilson-d’Almeida K, Aubrière C, Marcellin F, Spire B, Lert F, et al. Health status of people living with HIV followed at hospital in metropolitan France in 2011 and characteristics of those recently diagnosed Results of the ANRS VESPA2 study. Bull Epidémiologique Hebd. 2013;26(27):285–92.
36.
go back to reference Saboni L, Beltzer N, The KAPB Study Group. HIV knowledge, attitude, beliefs, and practices in France from 1992 to 2010. KABP ANRS-ORS-Inpes-IReSP-DGS survey. Bull Epidémiologique Hebd. 2012;46(47):525–9. Saboni L, Beltzer N, The KAPB Study Group. HIV knowledge, attitude, beliefs, and practices in France from 1992 to 2010. KABP ANRS-ORS-Inpes-IReSP-DGS survey. Bull Epidémiologique Hebd. 2012;46(47):525–9.
37.
go back to reference Préau M, Laguette V, March L, Rabaud C, Hardel L, Protopopescu C, et al. Discussing HIV status: is it easier after 10 years of antiretroviral treatment? The ANRS CO8 APROCO-COPILOTE cohort. AIDS Behav. 2016;24:1–11. Préau M, Laguette V, March L, Rabaud C, Hardel L, Protopopescu C, et al. Discussing HIV status: is it easier after 10 years of antiretroviral treatment? The ANRS CO8 APROCO-COPILOTE cohort. AIDS Behav. 2016;24:1–11.
38.
39.
go back to reference Petrak JA, Doyle AM, Smith A, Skinner C, Hedge B. Factors associated with self-disclosure of HIV serostatus to significant others. Br J Health Psychol. 2001;6(Pt 1):69–79.PubMedCrossRef Petrak JA, Doyle AM, Smith A, Skinner C, Hedge B. Factors associated with self-disclosure of HIV serostatus to significant others. Br J Health Psychol. 2001;6(Pt 1):69–79.PubMedCrossRef
40.
go back to reference Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care. 2008;20(10):1266–75.PubMedCrossRef Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care. 2008;20(10):1266–75.PubMedCrossRef
41.
go back to reference Hoover MA, Green HD, Bogart LM, Wagner GJ, Mutchler MG, Galvan FH, et al. Do people know I’m poz?: factors associated with knowledge of serostatus among HIV-positive African Americans’ social network members. AIDS Behav. 2016;20(1):137–46.PubMedPubMedCentralCrossRef Hoover MA, Green HD, Bogart LM, Wagner GJ, Mutchler MG, Galvan FH, et al. Do people know I’m poz?: factors associated with knowledge of serostatus among HIV-positive African Americans’ social network members. AIDS Behav. 2016;20(1):137–46.PubMedPubMedCentralCrossRef
42.
go back to reference Coutherut J, Desclaux A. Le partage du statut sérologique avec l’entourage. In: Evaluation de l’impact bio-clinique et social, individuel et collectif, du traitement ARV chez des patients VIH-1 pris en charge depuis 10 ans dans le cadre de l’ISAARV cohorte ANRS 1215—Rapport final. ANRS; 2012. Coutherut J, Desclaux A. Le partage du statut sérologique avec l’entourage. In: Evaluation de l’impact bio-clinique et social, individuel et collectif, du traitement ARV chez des patients VIH-1 pris en charge depuis 10 ans dans le cadre de l’ISAARV cohorte ANRS 1215—Rapport final. ANRS; 2012.
43.
go back to reference Nachega JB, Morroni C, Zuniga JM, Sherer R, Beyrer C, Solomon S, et al. HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults. J Int Assoc Physicians AIDS Care. 2012;11(3):172–8.CrossRef Nachega JB, Morroni C, Zuniga JM, Sherer R, Beyrer C, Solomon S, et al. HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults. J Int Assoc Physicians AIDS Care. 2012;11(3):172–8.CrossRef
44.
go back to reference Klitzman RL, Kirshenbaum SB, Dodge B, Remien RH, Ehrhardt AA, Johnson MO, et al. Intricacies and inter-relationships between HIV disclosure and HAART: a qualitative study. AIDS Care. 2004;16(5):628–40.PubMedCrossRef Klitzman RL, Kirshenbaum SB, Dodge B, Remien RH, Ehrhardt AA, Johnson MO, et al. Intricacies and inter-relationships between HIV disclosure and HAART: a qualitative study. AIDS Care. 2004;16(5):628–40.PubMedCrossRef
45.
go back to reference Roux P, Fugon L, Michel L, Lert F, Obadia Y, Spire B, et al. Determinants of benzodiazepine use in a representative population of HIV-infected individuals: the role of HIV status disclosure (ANRS-EN12-VESPA study). AIDS Care. 2011;23(9):1163–70.PubMedCrossRef Roux P, Fugon L, Michel L, Lert F, Obadia Y, Spire B, et al. Determinants of benzodiazepine use in a representative population of HIV-infected individuals: the role of HIV status disclosure (ANRS-EN12-VESPA study). AIDS Care. 2011;23(9):1163–70.PubMedCrossRef
Metadata
Title
Disclosure of HIV Status Beyond Sexual Partners by People Living with HIV in France: A Call for Help? Results from the National Cross-Sectional Survey ANRS-VESPA2
Authors
Fabienne Marcellin
Marie Suzan-Monti
Antoine Vilotitch
Luis Sagaon-Teyssier
Marion Mora
Rosemary Dray-Spira
Marie Préau
France Lert
Bruno Spire
The ANRS VESPA2 Study Group
Publication date
01-01-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1549-9

Other articles of this Issue 1/2017

AIDS and Behavior 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.